Abstract
Venous malformations are congenital low-flow vascular malformations. Venous malformations commonly present in the skin and superficial soft tissues; they can involve deeper structures. Venous malformations are associated with other vascular anomaly syndromes as well. Common presenting symptoms include swelling, pain, mass effect, and psychosocial stressors. Coagulopathy is observed with diffuse and multifocal lesions. Ultrasonography and magnetic resonance imaging are useful adjuncts for diagnosis and understanding extent and relationship to adjacent structures. Mainstays of therapy include expectant management, compression, pain control, sclerotherapy, and surgical resection. Multimodal and interdisciplinary care is crucial to provide comprehensive care to patients with venous malformations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012;68(2):198–201.
Masson P. Hemangioendotheliome vegetant intravasculaire. Anat Paris. 1923;93:517.
Kozakewich HPMJ. Histopathology of vascular malformations. In: Mulliken JB, Burrows P, Fishman SJ, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 480–507.
Alomari AI, Spencer SA, Arnold RW, et al. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop. 2014;34(1):109–17.
Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol. 2004;140(8):971–6.
Limaye N, Wouters V, Uebelhoer M, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet. 2009;41(1):118–24.
Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol. 2013;4(4):179–83.
Natynki M, Kangas J, Miinalainen I, et al. Common and specific effects of TIE2 mutations causing venous malformations. Hum Mol Genet. 2015;24(22):6374–89.
Greene AK, Goss JA. Vascular anomalies: from a clinicohistologic to a genetic framework. Plast Reconstr Surg. 2018;141(5):709e–17e.
Vikkula M, Boon LM, Carraway KL 3rd, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87(7):1181–90.
Vikkula M, Boon LM, Mulliken JB, Olsen BR. Molecular basis of vascular anomalies. Trends Cardiovasc Med. 1998;8(7):281–92.
Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996;87(7):1171–80.
Wouters V, Limaye N, Uebelhoer M, et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet. 2010;18(4):414–20.
Brouillard P, Boon LM, Revencu N, et al. Genotypes and phenotypes of 162 families with a glomulin mutation. Mol Syndromol. 2013;4(4):157–64.
Boon LM, Brouillard P, Irrthum A, et al. A gene for inherited cutaneous venous anomalies (“glomangiomas”) localizes to chromosome 1p21-22. Am J Hum Genet. 1999;65(1):125–33.
Brouillard P, Boon LM, Mulliken JB, et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”). Am J Hum Genet. 2002;70(4):866–74.
Boon L, Vikkula M. Molecular genetics of vascular malformations. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Youngs’ vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 327–75.
Cotten A, Flipo RM, Herbaux B, Gougeon F, Lecomte-Houcke M, Chastanet P. Synovial haemangioma of the knee: a frequently misdiagnosed lesion. Skelet Radiol. 1995;24(4):257–61.
Devaney K, Vinh TN, Sweet DE. Synovial hemangioma: a report of 20 cases with differential diagnostic considerations. Hum Pathol. 1993;24(7):737–45.
Spencer SA, Sorger J. Orthopedic issues in vascular anomalies. Semin Pediatr Surg. 2014;23(4):227–32.
Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg. 2000;37(8):517–84.
Fishman SJ, Fox VL. Visceral vascular anomalies. Gastrointest Endosc Clin N Am. 2001;11(4):813–34.. viii
Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg. 1998;33(7):1163–7.
Kulungowski AM, Fox VL, Burrows PE, Alomari AI, Fishman SJ. Portomesenteric Venous Thrombosis Associated with Rectal Venous Malformation. J Pediatr Surg. 2010.(in press;45:1221.
MacSween RM, Anthony PP, Scheuer PJ. Pathology of the liver. New York: Churchill Livingstone; 1987.
Fishman S. Truncal, visceral, and genital vascular malformations. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Young's Vascular Anomalies: Hemangiomas and Malformations. 2nd ed. New York: Oxford University Press; 2013. p. 966–1016.
Jahn H, Nissen HM. Haemangioma of the urinary tract: review of the literature. Br J Urol. 1991;68(2):113–7.
Greene AK, Rogers GF, Mulliken JB. Intraosseous “hemangiomas” are malformations and not tumors. Plast Reconstr Surg. 2007;119(6):1949–50; author reply 1950.
Mounayer C, Wassef M, Enjolras O, Boukobza M, Mulliken JB. Facial “glomangiomas”: large facial venous malformations with glomus cells. J Am Acad Dermatol. 2001;45(2):239–45.
Mallory SB, Enjolras O, Boon LM, et al. Congenital plaque-type glomuvenous malformations presenting in childhood. Arch Dermatol. 2006;142(7):892–6.
Ardillon L, Lambert C, Eeckhoudt S, Boon LM, Hermans C. Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations. Blood Coagul Fibrinolysis. 2015;27(2):216–9.
Bean W. Blue rubber-bleb nevi of the skin and gastrointestinal tract. In: Vascular spiders and related lesions of the skin, vol. 1958. Springfield: Charles C Thomas. p. 17–185.
Gascoyen M. Case of naevus involving the parotid gland and causing suffocation. Trans Pathol Soc (Lond). 1860;11:267.
Fishman SJ, Smithers CJ, Folkman J, et al. Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg. 2005;241(3):523–8.
Beluffi G, Romano P, Matteotti C, Minniti S, Ceffa F, Morbini P. Jejunal intussusception in a 10-year-old boy with blue rubber bleb nevus syndrome. Pediatr Radiol. 2004;34(9):742–5.
Lee C, Debnath D, Whitburn T, Farrugia M, Gonzalez F. Synchronous multiple small bowel intussusceptions in an adult with blue rubber bleb naevus syndrome: report of a case and review of literature. World J Emerg Surg. 2008;3:3.
Fishman G, DeRowe A, Singhal V. Congenital internal and external jugular venous aneurysms in a child. Br J Plast Surg. 2004;57(2):165–7.
Kulungowski AM, Fishman SJ. Management of combined vascular malformations. Clin Plast Surg. 2011;38(1):107–20.
Reis J, Alomari AI, Trenor CC, et al. Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal abnormalities and Klippel-Trénaunay syndrome. J Vasc Surg Venous Lymphat Disord. 2018;6(4):511–6.
Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol. 1997;36(2. Pt 1):219–25.
Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol. 2008;144(7):861–7.
Adams D, Neufeld E. Coagulopathy and vascular malformations. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 637–44.
Rodríguez-Mañero M, Aguado L, Redondo P. Pulmonary arterial hypertension in patients with slow-flow vascular malformations. Arch Dermatol. 2010;146(12):1347–52.
Nguyen JT, Koerper MA, Hess CP, et al. Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences. Pediatr Dermatol. 2014;31(5):556–60.
Lee DF, Hung MC. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle. 2007;6(24):3011–4.
Erickson J, McAuliffe W, Blennerhassett L, Halbert A. Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients. Pediatr Dermatol. 2017;34(6):e317–20.
Salloum R, Fox CE, Alvarez-Allende CR, et al. Response of blue rubber bleb nevus syndrome to Sirolimus treatment. Pediatr Blood Cancer. 2016;63(11):1911–4.
Hammer J, Seront E, Duez S, et al. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study. Orphanet J Rare Dis. 2018;13(1):191.
Burrows P. Percutaneous treatment of slow-flow vascular malformations. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 661–709.
Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004;15(5):431–45.
Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139(11):1409–16.
Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104(1):1–11; discussion 12–15.
Shaikh R, Alomari AI, Kerr CL, Miller P, Spencer SA. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option. Pediatr Radiol. 2016;46(8):1179–86.
Barranco-Pons R, Burrows PE, Landrigan-Ossar M, Trenor CC, Alomari AI. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures. AJR Am J Roentgenol. 2012;199(3):691–4.
Uller W, El-Sobky S, Alomari AI, et al. Preoperative embolization of venous malformations using n-Butyl Cyanoacrylate. Vasc Endovasc Surg. 2018;52(4):269–74.
Tieu DD, Ghodke BV, Vo NJ, Perkins JA. Single-stage excision of localized head and neck venous malformations using preoperative glue embolization. Otolaryngol Head Neck Surg. 2013;148(4):678–84.
Upton IIIJ. Vascular malformations of the extremities. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 903–65.
Borsellino A, Poggiani C, Alberti D, et al. Lower gastrointestinal bleeding in a newborn caused by isolated intestinal vascular malformation. Pediatr Radiol. 2003;33(1):41–3.
Fishman SJ, Shamberger RC, Fox VL, Burrows PE. Endorectal pull-through abates gastrointestinal hemorrhage from colorectal venous malformations. J Pediatr Surg. 2000;35(6):982–4.
Kulungowski AM, Schook CC, Alomari AI, Vogel AM, Mulliken JB, Fishman SJ. Vascular anomalies of the male genitalia. J Pediatr Surg. 2011;46(6):1214–21.
Smithers CJ, Vogel AM, Kozakewich HP, et al. An injectable tissue-engineered embolus prevents luminal recanalization after vascular sclerotherapy. J Pediatr Surg. 2005;40(6):920–5.
Kulungowski AM, Hassanein AH, Foster CC, Greene AK, Fishman SJ. Bevacizumab and interferon reduce venous recanalization following sclerotherapy. J Pediatr Surg. 2016;51(10):1670–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kulungowski, A.M., Patel, M.N., Fishman, S.J. (2020). Venous Malformations and Associated Syndromes: Diagnosis and Management. In: Trenor III, C., Adams, D. (eds) Vascular Anomalies. Springer, Cham. https://doi.org/10.1007/978-3-030-25624-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-25624-1_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25622-7
Online ISBN: 978-3-030-25624-1
eBook Packages: MedicineMedicine (R0)